Last reviewed · How we verify

Levocarnitine Acetyl — Competitive Intelligence Brief

Levocarnitine Acetyl (ACETYLCARNITINE) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Carnitine Analog. Area: Neuroscience.

discontinued Carnitine Analog Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Levocarnitine Acetyl (ACETYLCARNITINE). Acetylcarnitine works by supporting the transport of fatty acids into mitochondria, where they can be used for energy production.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Levocarnitine Acetyl TARGET ACETYLCARNITINE discontinued Carnitine Analog
Carnitor LEVOCARNITINE Leadiant Biosci Inc marketed Carnitine Analog [EPC] Carnitine O-palmitoyltransferase 1, liver isoform 1985-01-01
CARNITINE CARNITINE marketed Carnitine Analog [EPC]
L-Ornithine ORNITHINE marketed Carnitine Analog [EPC] G-protein coupled receptor family C group 6 member A
L-carnitine L-carnitine Asan Medical Center marketed Carnitine Analog [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Carnitine Analog class)

  1. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Levocarnitine Acetyl — Competitive Intelligence Brief. https://druglandscape.com/ci/acetylcarnitine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: